Blume Equity Expands with New Investor Partners

Blume Equity expands its investor base with British Patient Capital and Queensland Investment Corporation to accelerate climate-tech investments in Europe.

Blume Equity LLP has secured British Patient Capital and Queensland Investment Corporation as limited partners. This development marks a crucial milestone for Blume Equity, a growth-stage venture investor focused on supporting businesses addressing climate and environmental challenges across Europe.

The Investment

British Patient Capital, a subsidiary of the British Business Bank, has made a €25 million commitment to Blume Equity's Fund I. This investment will enable Blume Equity to further its mission of investing in companies that are driving the transition to a net-zero economy. Blume Equity's Fund I is focused on investing in growth-stage companies that are tackling the climate crisis and promoting sustainable development.

A Commitment to Diversity and Inclusion

Both British Patient Capital and Blume Equity have signed the Investing in Women Code, a pledge to support the advancement of female entrepreneurship in the United Kingdom. This commitment reflects the companies' shared values of promoting diversity and inclusion in the venture capital sector. Currently, only 11% of senior investment roles at UK firms and their European offices are held by women, highlighting the need for initiatives like this to drive change.

A Partnership for Growth

The partnership between Blume Equity, British Patient Capital, and Queensland Investment Corporation will enable the growth of climate-tech companies across Europe. Blume Equity's investment focus aligns with British Patient Capital's commitment to supporting the transition to a modern, green economy. Queensland Investment Corporation's partnership with Blume Equity further cements its commitment to investing in funds and companies that are at the forefront of developing and implementing energy transition and climate solutions.

Leadership and Expertise

Blume Equity is led by a team of experienced investment professionals, including Clare Murray, Michelle Capiod, and Eleanor Blagbrough. The company has offices in London and Amsterdam and is 100% female-owned and led. British Patient Capital's Managing Director, Christine Hockley, and Queensland Investment Corporation's Partner, Toby Suen, have both expressed their enthusiasm for the partnership and the potential for growth and impact.

The partnership between Blume Equity, British Patient Capital, and Queensland Investment Corporation marks a significant step forward for the growth of climate-tech investments in Europe. With a shared commitment to promoting sustainable development and supporting female entrepreneurship, these companies are poised to drive positive change and generate strong returns. As the world continues to grapple with the challenges of climate change, investments like these will be critical to achieving a more sustainable future.